| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00019227 |
| P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
| phase II clinical trial | Q42824440 | ||
| P17 | country | United States of America | Q30 |
| P1050 | medical condition | lymphoma | Q208414 |
| leukemia | Q29496 | ||
| P2899 | minimum age | 18 | |
| P4844 | research intervention | edetic acid | Q408032 |
| calcium oxalate | Q412399 | ||
| pentetic acid | Q416487 | ||
| P580 | start time | 1996-10-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | PHASE I/II STUDY OF TAC-EXPRESSING ADULT T-CELL LEUKEMIA (ATL) WITH YTTRIUM-90 (90Y)-RADIOLABELED HUMANIZED ANTI-TAC AND CALCIUM-DTPA |